Qingde Wa

1.3k total citations
35 papers, 968 citations indexed

About

Qingde Wa is a scholar working on Cancer Research, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Qingde Wa has authored 35 papers receiving a total of 968 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cancer Research, 14 papers in Molecular Biology and 8 papers in Biomedical Engineering. Recurrent topics in Qingde Wa's work include MicroRNA in disease regulation (10 papers), Cancer-related molecular mechanisms research (10 papers) and Bone Tissue Engineering Materials (8 papers). Qingde Wa is often cited by papers focused on MicroRNA in disease regulation (10 papers), Cancer-related molecular mechanisms research (10 papers) and Bone Tissue Engineering Materials (8 papers). Qingde Wa collaborates with scholars based in China, United States and Canada. Qingde Wa's co-authors include Yongxiang Luo, Shuai Huang, Dong Ren, Xinsheng Peng, Yuxiao Li, Jincheng Pan, Yubo Tang, Yan Huang, Xuenong Zou and Peiheng He and has published in prestigious journals such as PLoS ONE, Scientific Reports and Acta Biomaterialia.

In The Last Decade

Qingde Wa

32 papers receiving 963 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qingde Wa China 16 517 460 205 119 112 35 968
Shuo Ni China 15 395 0.8× 195 0.4× 104 0.5× 203 1.7× 87 0.8× 25 817
Gemma Di Pompo Italy 18 449 0.9× 230 0.5× 219 1.1× 99 0.8× 279 2.5× 30 905
Alain van Mil Netherlands 21 1.1k 2.2× 775 1.7× 219 1.1× 56 0.5× 68 0.6× 42 1.7k
Yibing Guo China 21 601 1.2× 302 0.7× 252 1.2× 70 0.6× 146 1.3× 71 1.3k
Chuanjie Zhang China 21 732 1.4× 353 0.8× 103 0.5× 364 3.1× 184 1.6× 58 1.4k
Valeria Carina Italy 24 724 1.4× 419 0.9× 235 1.1× 75 0.6× 212 1.9× 34 1.3k
Shisheng Li China 18 466 0.9× 270 0.6× 196 1.0× 122 1.0× 122 1.1× 68 974

Countries citing papers authored by Qingde Wa

Since Specialization
Citations

This map shows the geographic impact of Qingde Wa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingde Wa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingde Wa more than expected).

Fields of papers citing papers by Qingde Wa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingde Wa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingde Wa. The network helps show where Qingde Wa may publish in the future.

Co-authorship network of co-authors of Qingde Wa

This figure shows the co-authorship network connecting the top 25 collaborators of Qingde Wa. A scholar is included among the top collaborators of Qingde Wa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingde Wa. Qingde Wa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Jingjing, Dan Feng, Jing Gong, et al.. (2025). Latent profiles and determinants of postoperative sleep quality in elective surgery patients. Scientific Reports. 15(1). 617–617.
2.
Xie, Qiuping, Guang‐Quan Zhao, Hao Tang, & Qingde Wa. (2025). Recent advances in understanding the role of Wnt5a in prostate cancer and bone metastasis. Discover Oncology. 16(1). 880–880.
3.
Wu, Honghan, et al.. (2025). Enhancement of in vitro and in vivo bone repair performance of decalcified bone/gelma by desferrioxamine. Scientific Reports. 15(1). 14092–14092. 1 indexed citations
4.
5.
Tang, Yubo, et al.. (2025). Zn-Mn-Mg alloy with superior mechanical properties and antibacterial performance. Advanced Composites and Hybrid Materials. 8(1). 2 indexed citations
6.
Dong, Yang, et al.. (2024). A DNA-inspired injectable adhesive hydrogel with dual nitric oxide donors to promote angiogenesis for enhanced wound healing. Acta Biomaterialia. 176. 128–143. 35 indexed citations
7.
Wa, Qingde, Penghui Zhang, Sien Lin, et al.. (2024). Mesoporous bioactive glass-enhanced MSC-derived exosomes promote bone regeneration and immunomodulation in vitro and in vivo. Journal of Orthopaedic Translation. 49. 264–282. 6 indexed citations
8.
Tang, Yubo, Qingde Wa, Longyun Peng, et al.. (2022). Salvianolic Acid B Suppresses ER Stress‐Induced NLRP3 Inflammasome and Pyroptosis via the AMPK/FoxO4 and Syndecan‐4/Rac1 Signaling Pathways in Human Endothelial Progenitor Cells. Oxidative Medicine and Cellular Longevity. 2022(1). 8332825–8332825. 36 indexed citations
9.
Chen, Chen, Xintao Zhang, Jiangyi Wu, et al.. (2021). Circ_HECW2 regulates LPS‐induced apoptosis of chondrocytes via miR‐93 methylation. Immunity Inflammation and Disease. 9(3). 943–949. 8 indexed citations
10.
Lin, Zhuoyuan, Sheng Huang, Yixiao Wang, et al.. (2021). Perillaldehyde inhibits bone metastasis and receptor activator of nuclear factor-κB ligand (RANKL) signaling-induced osteoclastogenesis in prostate cancer cell lines. Bioengineered. 13(2). 2710–2719. 28 indexed citations
11.
Wa, Qingde, Changye Zou, Zhuoyuan Lin, et al.. (2020). Ectopic Expression of miR-532-3p Suppresses Bone Metastasis of Prostate Cancer Cells via Inactivating NF-κB Signaling. Molecular Therapy — Oncolytics. 17. 267–277. 30 indexed citations
12.
Yang, Zhen, et al.. (2020). miR-23a-3p regulated by LncRNA SNHG5 suppresses the chondrogenic differentiation of human adipose-derived stem cells via targeting SOX6/SOX5. Cell and Tissue Research. 383(2). 723–733. 15 indexed citations
13.
Wa, Qingde, Sheng Huang, Jincheng Pan, et al.. (2019). miR-204-5p Represses Bone Metastasis via Inactivating NF-κB Signaling in Prostate Cancer. Molecular Therapy — Nucleic Acids. 18. 567–579. 49 indexed citations
14.
Pan, Jincheng, Shuai Huang, Xinsheng Peng, et al.. (2018). Downregulation of miR-133a-3p promotes prostate cancer bone metastasis via activating PI3K/AKT signaling. Journal of Experimental & Clinical Cancer Research. 37(1). 160–160. 115 indexed citations
15.
Wa, Qingde, Shuai Huang, Peiheng He, et al.. (2017). miRNA-140 inhibits C3H10T1/2 mesenchymal stem cell proliferation by targeting CXCL12 during transforming growth factor-β3-induced chondrogenic differentiation. Molecular Medicine Reports. 16(2). 1389–1394. 9 indexed citations
16.
Huang, Shuai, Qingde Wa, Jincheng Pan, et al.. (2017). Downregulation of miR-141-3p promotes bone metastasis via activating NF-κB signaling in prostate cancer. Journal of Experimental & Clinical Cancer Research. 36(1). 173–173. 94 indexed citations
17.
Wa, Qingde, Li Li, Hongcheng Lin, et al.. (2017). Downregulation of miR‑19a‑3p promotes invasion, migration and bone metastasis via activating TGF‑β signaling in prostate cancer. Oncology Reports. 39(1). 81–90. 50 indexed citations
18.
Huang, Sheng, Yubo Tang, Xinsheng Peng, et al.. (2016). Acidic extracellular pH promotes prostate cancer bone metastasis by enhancing PC-3 stem cell characteristics, cell invasiveness and VEGF-induced vasculogenesis of BM-EPCs. Oncology Reports. 36(4). 2025–2032. 46 indexed citations
19.
Guo, Yuanqing, Xinsheng Peng, Xintao Zhang, et al.. (2015). Inhibitory action of pristimerin on hypoxia-mediated metastasis involves stem cell characteristics and EMT in PC-3 prostate cancer cells. Oncology Reports. 33(3). 1388–1394. 31 indexed citations
20.
Zhao, Min, Ning Fang, Hui Du, et al.. (2006). Increased glycophorin A somatic cell variant frequency in arsenic-exposed patients of Guizhou, China. Toxicology Letters. 167(1). 47–53. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026